More than 50 years of work have led to the recognition of trivalent ch
romium as an essential element Shortly after its identification as an
essential element in 1959, its interaction with insulin in vitro and i
n vivo was established, and the site of action identified as the insul
in-sensitive cell membrane. Despite other early clinical successes wit
h chromium supplementation, four major problems have influenced the ra
te of progress since then: 1) chromium analysis; 2) interaction bf chr
omium with other dietary factors; 3) diagnosis of chromium status; and
4) other controversies, such as the carcinogenic potential of chromiu
m (since disproved) and the lack of an effect on glucose tolerance eve
n in chromium deficient organisms (now explained). These controversies
have mostly dissipated as new knowledge integrated seemingly irreconc
ilable facts and opinions. It is now known that chromium may potentiat
e the action of insulin either by an effect on insulin dependent funct
ions, or by maintaining these functions with less insulin, or by a com
bination of both. Despite much progress in the last 30 years, major ch
allenges in chromium research remain, such as the development of pract
ical methods for diagnosing chromium deficiency, Of several approaches
for solving this problem, the most feasible might be to standardize t
he urinary chromium response following an insulinogenic challenge, suc
h as an oral load of glucose or of glucose pins fructose (for maximal
stimulation) with wine collection before and during the 2-hour test.